The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
Abstract
Recent prospective investigations have reported that higher plasma fibrinogen concentrations and higher factor VII coagulant activity are associated with greater risk of cardiovascular disease. To discover what characteristics may influence fibrinogen and factor VII, we analyzed data from the Atherosclerosis Risk in Communities Study obtained from over 12,000 men and women, aged 45-64 years, from four communities in December 1986 to June 1989. Fibrinogen was higher in blacks than whites and in women than men; in general, it increased with age, smoking, body size, diabetes, fasting serum insulin, LDL cholesterol, lipoprotein(a), leukocyte count, and menopause, and it decreased with ethanol intake, physical activity, HDL cholesterol, and female hormone use. Factor VII was higher in women than men and, in women, increased with age; in both sexes, it increased with body size, triglycerides, LDL cholesterol, and HDL cholesterol, and it decreased with ethanol intake. These findings indicate that elevations in fibrinogen and factor VII may be modifiable through appropriate lifestyle changes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas the MS may play a limited role in accelerating atherosclerotic progression, it may significantly increase the risk of vascular events through prothrombotic or inflammatory mechanisms.29 -31”
From Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women (2006) · cites this paper as [31]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239
(1989) · PubMed · Cited by 3,139
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387
Siedel, J., Hägele, E., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915
Cited by
Sorted by citations
Rimm, E. B., Williams, P., Fosher, K., Criqui, M., & Stampfer, M. J. (1999) · BMJ · doi:10.1136/bmj.319.7224.1523 · Cited by 1,360
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805
Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease
Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 730
Self-citationPlasma proteomic signature of age in healthy humans
Tanaka, T., Biancotto, A., Moaddel, R., Moore, A. Z., Gonzalez‐Freire, M., Aon, M. A., Candia, J., Zhang, P., Cheung, F., Fantoni, G., et al. (2018) · Aging Cell · doi:10.1111/acel.12799 · Cited by 562
Woodhouse, P. R., Khaw, K., Plummer, M., Meade, T. W., & Foley, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92689-1 · Cited by 553
Morrissey, J. H., Macik, B., Neuenschwander, P., & Comp, P. (1993) · Blood · doi:10.1182/blood.v81.3.734.734 · Cited by 511
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
Wannamethee, S. G., Lowe, G. D. O., Whincup, P. H., Rumley, A., Walker, M., & Lennon, L. (2002) · Circulation · doi:10.1161/01.cir.0000016346.14762.71 · Cited by 487
Diabetes mellitus as a prothrombotic condition
Grant, P. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01824.x · Cited by 443
von Känel, R., Mills, P. J., Fainman, C., & Dimsdale, J. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00003 · Cited by 422
“There is substantial evidence that socioeconomic status is inversely related to plasma fibrinogen (84, 101, 103, 105, 108, 109, 113–122) and FVII levels (101, 114, 117, 121).”
BackgroundSmith, N. L., Chen, M., Dehghan, A., Strachan, D. P., Basu, S., Soranzo, N., Hayward, C., Rudan, I., Sabater‐Lleal, M., Bis, J. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.869156 · Cited by 379
Self-citationScarabin, P., Alhenc‐Gelas, M., Plu‐Bureau, G., Taisne, P., Agher, R., & Aiach, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3071 · Cited by 346
Cardiac rehabilitation past, present and future: an overview.
Mampuya, W. M. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2012.01.02 · Cited by 336
“Possible explanations for moderate alcohol consumption benefits include: HDL increase by stimulating the hepatic production of apo A-I and A-II, fibrinogen levels reduction, fibrinolysis stimulation, inflammation reduction and inhibition of platelet activation (61-65).”
BackgroundPeter, R., Alfredsson, L. S., Hammar, N., Siegrist, J., Theorell, T., & Westerholm, P. J. M. (1998) · Journal of Epidemiology & Community Health · doi:10.1136/jech.52.9.540 · Cited by 270
Fibrinogen: biochemistry, epidemiology and determinants
Kamath, S., & Lip, G. Y. H. (2003) · QJM · doi:10.1093/qjmed/hcg129 · Cited by 261
Brunner, E. J., Marmot, M. G., Canner, R., Beksinska, M., Smith, G. D., & O'Brien, J. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90147-6 · Cited by 260
Bostom, A. G., GAGNON, D. R., Cupples, L. A., Wilson, P. W. F., Jenner, J. L., Ordovás, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 254
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis
Melnick, S. L., Shahar, E., Folsom, A. R., Grayston, J. T., Sorlie, P. D., Wang, S.-P., & Szklo, M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90332-j · Cited by 246
Self-citationMcCarty, M. F. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0684 · Cited by 235
Review article: Coagulation and fibrinolysis in diabetes
Alzahrani, S. H., & Ajjan, R. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110383723 · Cited by 234
“An association between fibrinogen levels, insulin and low high-density lipoprotein has been documented, indicating this protein is part of the cardiovascular risk cluster in diabetes.(21,37,38) High fibrinogen levels have been shown to predict progression of coronary artery calcification in T1DM,(39) and levels of thi…”
Background(2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm191 · Cited by 227
“Ethnicity, socioeconomic status, and season Adjusted mean fibrinogen levels were approximately 0.12 g/liter higher in Blacks than in Whites (35).”
BackgroundInfluentialFolsom, A. R., Qamhieh, H. T., Wing, R. R., Jeffery, R. W., Stinson, V., Kuller, L. H., & Wu, K. K. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.162 · Cited by 224
Self-citationSara, J. D. S., Prasad, M., Eleid, M. F., Zhang, M., Widmer, R. J., & Lerman, A. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008073 · Cited by 226
Folsom, A. R., Wu, K. K., Shahar, E., & DAVIS, C. E. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1829 · Cited by 186
Self-citationVirchow’s Triad Revisited: Blood Constituents
Chung, I. K.-K., & Lip, G. Y. H. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083844 · Cited by 161
The role of estrogen in cardiovascular disease
Baker, L., Meldrum, K. K., Wang, M., Sankula, R., Vanam, R. P., Raiesdana, A., Tsai, B. M., Hile, K. L., Brown, J. W., & Meldrum, D. R. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00215-4 · Cited by 163
Statin Therapy in Acute Coronary Syndromes
Sposito, A. C., & Chapman, M. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000032033.39301.6a · Cited by 157
Helicobacter pylori Seropositivity and Coronary Heart Disease Incidence
Folsom, A. R., Nieto, F. J., Sorlie, P. D., Chambless, L. E., & Graham, D. Y. (1998) · Circulation · doi:10.1161/01.cir.98.9.845 · Cited by 159
Self-citationWoodward, M., Lowe, G. D. O., Rumley, A., Tunstall‐Pedoe, H., Philippou, H., Lane, D. A., & Morrison, C. E. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.1232935.x · Cited by 155
Plasma Fibrinogen: A New Factor of the Metabolic Syndrome: A population-based study
Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A. A., & Vaccaro, O. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.649 · Cited by 151
Kario, K., Matsuo, T., Kobayashi, H., Matsuo, M., Sakata, T., & Miyata, T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1114 · Cited by 149
Stensvold, I., Tverdal, A., Urdal, P., & Graff‐Iversen, S. (1993) · BMJ · doi:10.1136/bmj.307.6915.1318 · Cited by 142
Juhan-Vague, I., Alessi, M., & Vague, P. (1996) · Annals of Medicine · doi:10.3109/07853899608999095 · Cited by 142
Visceral Fat Accumulation and Its Relation to Plasma Hemostatic Factors in Healthy Men
CIGOLINI, M., Targher, G., Andreis, I. A. B., Tonoli, M., Agostino, G., & Sandre, G. D. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.368 · Cited by 141
Eliasson, M. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05425-i · Cited by 140
Pieper, C. F., Rao, K. M. K., Currie, M. S., Harris, T. B., & Cohen, H. J. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.11.m649 · Cited by 138
Plasma albumin and platelet function: relevance to atherogenesis and thrombosis
Mikhailidis, D. P., & Ganotakis, E. S. (1996) · Platelets · doi:10.3109/09537109609023571 · Cited by 129
Characteristics of Anticoagulant Therapy and Comorbidity Related to Overanticoagulation
Beest, F. P.-V., van Meegen, E., Rosendaal, F. R., & Stricker, B. H. C. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616088 · Cited by 127
“These factors may also affect the response to oral anticoagulants (19-24) and were thus considered as potential confounders.”
BackgroundWamala, S. P., Mittleman, M. A., Schenck-Gustafsson, K., & Orth-Gomér, K. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.3.315 · Cited by 127
Hemostatic Risk Factors for Atherothrombotic Disease: An Epidemiologic View
Folsom, A. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616234 · Cited by 126
Self-citationSEARCHING FOR THE BIOLOGICAL PATHWAYS BETWEEN STRESS AND HEALTH
Kelly, S., Hertzman, C., & Daniel, M. (1997) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.18.1.437 · Cited by 123
Sanders, T. A. B., Oakley, F. R., Miller, G. J., Mitropoulos, K. A., Crook, D., & Oliver, M. F. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3449 · Cited by 122
Scarabin, P., Bara, L., Ricard, S., Poirier, O., Cambou, J., Arveiler, D., Luc, G., Evans, A. E., Samama, M. M., & Cambien, F. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.886 · Cited by 123
Functional Characterization of the Human Factor VII 5′-Flanking Region
Pollak, E. S., Hung, H.-L., Godin, W., Overton, G. C., & High, K. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1738 · Cited by 123
Hormone Replacement Therapy and the Cardiovascular System
Stevenson, J. C., Crook, D., Godsland, I. F., Collins, P., & Whitehead, M. I. (1994) · Drugs · doi:10.2165/00003495-199400472-00007 · Cited by 117
“1990) and fibrinogen (Folsom et al. 1991), and the antifibrinolytic factor, plasminogen activator inhibitor-I (Heinrich et al.”
BackgroundGreen, F. R., Hamsten, A., Blombäck, M., & Humphries, S. E. (1993) · PubMed · Cited by 113
Shahar, E., Folsom, A. R., Wu, K. K., Dennis, B. H., Shimakawa, T., Conlan, M. G., DAVIS, C. E., & Williams, O. D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1205 · Cited by 116
Self-citationHumphries, S. E., Ye, S., Talmud, P. J., Bara, L., Wilhelmsen, L., & Tiret, L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.96 · Cited by 108
Coagulation and atherothrombotic disease
Ajjan, R., & Grant, P. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.042 · Cited by 106
Trends in coronary artery disease and associated risk factors in sub-Saharan Africans
Akinboboye, O., Idris, O., Akinboboye, O., & Akinkugbe, O. O. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001562 · Cited by 104
Stensland-Bugge, E., Bønaa, K. H., & Joakimsen, O. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00486-x · Cited by 101
“Smoking is the most important lifestyle determinant of fibrinogen [20].”
BackgroundMansfield, M. W., Heywood, D. M., & Grant, P. J. (1996) · Circulation · doi:10.1161/01.cir.94.9.2171 · Cited by 100
Fibrinogen and Cardiovascular Risk
Ernst, E., & Köenig, W. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200207 · Cited by 99
Activation of the Coagulant Pathway in Cigarette Smokers
Bauer, K. A., Cooper, J. A., ROSENBERG, R. D., & Miller, G. J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614942 · Cited by 97
“Neither of these possibilities, however, would appear to explain the reduction in VIIc observed in cigarette smokers in some studies (18, 42, 43).”
BackgroundInfluentialUpdate on cardiovascular disease in post-menopausal women
Gorodeski, G. I. (2002) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2002.0282 · Cited by 93
Eliasson, M., Evrin, P., & Lundblad, D. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90298-4 · Cited by 96
Venous thromboembolism and ethnicity
Roberts, L. N., Patel, R., & Arya, R. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07786.x · Cited by 94
“This contrasts with previous studies in which African-Americans were found to have significantly higher fibrinogen levels (by 0Æ1–0Æ6 g/l) compared to US whites (Folsom et al, 1991; Folsom et al, 1993).”
ResultInsulin resistance syndrome: interaction with coagulation and fibrinolysis
Köhler, H.-P. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.09856 · Cited by 95
Kunutsor, S. K., Mäkikallio, T. H., Seidu, S., de Araújo, C. G. S., Dey, R. S., Blom, A. W., & Laukkanen, J. A. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00579-2 · Cited by 96
Lakka, T. A., & Salonen, J. T. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90111-d · Cited by 95
Population Correlates of Coagulation Factor VII
Scarabin, P., Vissac, A., Kirzin, J.-M., Bourgeat, P., Amiral, J., Agher, R., & Guize, L. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1170 · Cited by 91
Heit, J. A., Beckman, M. G., Bockenstedt, P. L., Grant, A. M., Key, N. S., Kulkarni, R., Manco‐Johnson, M. J., Moll, S., Ortel, T. L., & Philipp, C. S. (2010) · American Journal of Hematology · doi:10.1002/ajh.21735 · Cited by 86
“When compared with Whites, Blacks have higher levels of fibrinogen, [35,36,38] factor VIII, [37,38,44] von Willebrand factor [37,38,44], and plasma fibrin D-dimer [38,45,46], and lower levels of protein C [36].”
BackgroundResultLindqvist, P. G., Epstein, E., & Olsson, H. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07460.x · Cited by 86
“Plasma viscosity is determined largely by fibrinogen, and a negative relationship between fibrinogen and physical activity has been established (Folsom et al, 1991; Stratton et al, 1991).”
BackgroundInfluence of Fibrinogen on Cardiovascular Disease
Kannel, W. B. (1997) · Drugs · doi:10.2165/00003495-199700543-00006 · Cited by 86
Saloma, V., Rasi, V., Pekkanen, J., Jauhiainen, M., Vahtera, E. M., Pietinen, P., KORHONEN, H. J., Kuulasmaa, K., & Ehnholm, C. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90034-r · Cited by 84
Physical inactivity and idiopathic pulmonary embolism in women: prospective study
Kabrhel, C., Varraso, R., Goldhaber, S. Z., Rimm, E. B., & Camargo, C. A. (2011) · BMJ · doi:10.1136/bmj.d3867 · Cited by 80
Conquer, J. A., Cheryk, L. A., Chan, E., Gentry, P. A., & Holub, B. J. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00106-1 · Cited by 80
“factor VII, are positively associated with increased Internationally, the Inuit are thought to consume incidence of coronary artery disease [24–27].”
BackgroundPlasma fibrinogen and its correlates in Japanese and US population samples.
Iso, H., Folsom, A. R., Sato, S., Wu, K. K., Shimamoto, T., KOIKE, K., Iida, M., & Komachi, Y. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.783 · Cited by 80
Self-citationSanders, T. A. B., de Grassi, T., Miller, G. J., & Morrissey, J. H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00335-4 · Cited by 78
“FVIIc is positively associated with plasma triacylglycerol concentration [10] and habitual dietary fat intake [11].”
BackgroundFibrinogen Gene Promoter −455 A Allele as a Risk Factor for Lacunar Stroke
Martiskainen, M., Pohjasvaara, T., Mikkelsson, J., Mäntylä, R., Kunnas, T. A., Laippala, P., Ilveskoski, E., Kaste, M., Karhunen, P. J., & Erkinjuntti, T. (2003) · Stroke · doi:10.1161/01.str.0000060029.23872.55 · Cited by 79
Gender‐Specific Risk Factors for Peripheral Artery Disease in a Voluntary Screening Population
Hiramoto, J. S., Katz, R., Weisman, S. M., & Conte, M. S. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000651 · Cited by 75
“Fibrinogen levels also differ by gender and race and have been reported to be higher in women than men and in blacks compared to whites.(68,69,73) Adiponectin is the most abundant circulating adipokine and has both antiatherogenic and -inflammatory effects.”
BackgroundRelations between hemostasis variables and cardiovascular risk factors in middle-aged adults
Folsom, A. R., Conlan, M. G., DAVIS, C. E., & Wu, K. K. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90098-b · Cited by 75
Self-citationMennen, L. I., Balkau, B., Vol, S., Cacès, E., & Eschwège, E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.887 · Cited by 74
Low serum thyrotropin is associated with high plasma fibrinogen
Dörr, M., Robinson, D. M., Wallaschofski, H., Schwahn, C., John, U., Felix, S. B., & Völzke, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1786 · Cited by 73
Asthma and Its Association with Cardiovascular Disease in the Elderly
Enright, P., Ward, B. J., Tracy, R. P., & Lasser, E. C. (1996) · Journal of Asthma · doi:10.3109/02770909609077762 · Cited by 72
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance
Catena, C., Zingaro, L., Casaccio, D., & Sechi, L. A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00567-2 · Cited by 71
Meade, T. W. (1996) · BMJ · doi:10.1136/bmj.312.7029.473 · Cited by 71
Cook, D. G. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.8.799 · Cited by 70
“Moreover, in the United States where fibrinogen levels among US-born Blacks are reported to be similar to or higher than those in Whites (8, 9), CHD rates in Blacks are higher than those in Whites while stroke rates are four times higher than in Whites (21), a considerably higher relative risk than in the United Kingd…”
BackgroundResultKario, K., Miyata, T., Sakata, T., Matsuo, T., & Kato, H. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.265 · Cited by 70
“In adults, body mass index has been shown to have a positive correlation with plasma FVIIc level in a population study.(17)-(41) However, our previous study of subjects older than 60 years did not show any correlation between body mass index and either FVIIc or FVILAg levels.”
BackgroundBarazzoni, R., Zanetti, M., Davanzo, G., Kiwanuka, E., Carraro, P., Tiengo, A., & Tessari, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6779 · Cited by 68
“Based on the above observations it is therefore unlikely that these potential confounding factors (38, 39) contributed to the alterations of fibrinogen turnover reported in the current investigation.”
BackgroundResultDiabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic
King, R., & Grant, P. J. (2016) · Herz · doi:10.1007/s00059-016-4414-8 · Cited by 71
“This prediabetes phase is associated with many of the abnormalities frequently observed in T2DM, such as endothelial cell (EC) dysfunction [7, 8], elevated PAI-1 [9], fibrinogen[10], coagulation factorVII [11, 12], and inflammatory proteins [13, 14], with similarpatterns seen inhealthy firstdegree relatives of patient…”
BackgroundInteraction Between Alcohol and Exercise
Elsayed, M., Ali, N. S., & Ali, Z. E.-S. (2005) · Sports Medicine · doi:10.2165/00007256-200535030-00005 · Cited by 67
Oakley, F. R., Sanders, T. A. B., & Miller, G. J. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1202 · Cited by 67
Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women
Wamala, S. P., Mittleman, M. A., Horsten, M., Eriksson, M., Schenck-Gustafsson, K. G., Hamsten, A., Silveira, A. M. V., & Orth‐Gomér, K. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.485 · Cited by 65
“#1.15 mmol/L 3.46 (0.17) 1.25 (0.09) 452 ( 23 ) 4.9 (0.3) 7.7 (1.4) .1.15 mmol/L 3.16 (0.03) 1.09 (0.02) 416 (6) 4.9 (0.1) 2.9 (1.2) P 0.03 0.06 0.07 0.84 0.005”
InfluentialPregnancy-induced hypertension and insulin resistance, evidence for a connection
Innes, K. E., & Wimsatt, J. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.780401.x · Cited by 67
Beest, F. J. A. P., van Meegen, E., Rosendaal, F. R., & Stricker, B. H. C. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115723 · Cited by 63
Greendale, G. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040090010 · Cited by 64
Association Between Hypercoagulability and Severe Obstructive Sleep Apnea
Hong, S., Yun, H.-C., Yoo, J. H., & Lee, S. H. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.1367 · Cited by 69
Hormone therapy and venous thromboembolism
Peverill, R. E. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(02)00079-9 · Cited by 60
Regular exercise reduces fibrinogen levels: a review of longitudinal studies.
Ernst, E. (1993) · British Journal of Sports Medicine · doi:10.1136/bjsm.27.3.175 · Cited by 60
Nontraditional Cardiovascular Risk Factors
Oparil, S., & Oberman, A. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40503-8 · Cited by 62
Heywood, D. M., Carter, A. M., Catto, A. J., Bamford, J., & Grant, P. J. (1997) · Stroke · doi:10.1161/01.str.28.4.816 · Cited by 60
Hemostatic Factors and Estrogen during the Menopausal Transition
Sowers, M. R., Matthews, K. A., Jannausch, M. L., Randolph, J. F., McConnell, D. S., Sutton-Tyrrell, K., Little, R. J. A., Lasley, B. L., & Pasternak, R. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0591 · Cited by 59
Insulin Resistance Syndrome and Fibrinolytic Activity: The Northern Sweden MONICA Study
Lindahl, B., Asplund, K., Eliasson, M., & Evrin, P. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.2.291 · Cited by 59
Köenig, W., & Ernst, E. (2000) · Coronary Artery Disease · doi:10.1097/00019501-200003000-00006 · Cited by 58
Lifestyle and diet as risk factors for overanticoagulation
Beest, F. J. A. P., Geleijnse, J. M., van Meegen, E., Vermeer, C., Rosendaal, F. R., & Stricker, B. H. C. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00485-1 · Cited by 57
“A negative association with factor VII has been reported for physical activity, smoking, and intake of alcohol [ 8 ,9].”
BackgroundWinkler, U. H. (1992) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(92)90004-2 · Cited by 56
MacAuley, D., McCrum, E. E., STOTT, G., Evans, A. E., McRoberts, B., Boreham, C. A., Sweeney, K., & Trinick, T. R. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.3.258 · Cited by 55
Effect of Strenuous Exercise on Fibrinogen and Fibrinolysis in Healthy Elderly Men and Women
Schuit, A. J., Schouten, E. G., Kluft, C., de Maat, M. P. M., Menheere, P. P. C. A., & Kok, F. J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657639 · Cited by 55
Lifestyle factors and coagulation activation markers: the Caerphilly Study
YARNELL, J. W. G., Sweetnam, P. M., Rumley, A., & Lowe, G. D. O. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200112000-00015 · Cited by 54
“Factor VIIc showed a trend with body mass index as reported elsewhere [6,18]; weight reduction has been reported to lower VIIc levels [19].”
BackgroundTherapeutic interventions to lower plasma fibrinogen concentration
Ernst, E., & Resch, K. L. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_a.47 · Cited by 52
Metadata
- Authors
- FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M.
- Affiliations
- University of Minnesota (US)
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- Corresponding author
- FOLSOM, A
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 91
- Issue
- 3
- Pages
- 191-205
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2001322531
- Cited by
- 321
- References
- 52
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 6
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health (n01hc55016-37-0-0, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC-55018, N01-HC55016, N01‐HC‐55015)
- Topics
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- fibrinogen, factor VII coagulant activity, cardiovascular risk factors, cardiovascular disease, Atherosclerosis Risk in Communities Study, sex differences, racial differences, modifiable lifestyle factors, smoking, alcohol consumption, physical activity, diabetes mellitus, insulin, lipoprotein(a), LDL cholesterol, HDL cholesterol, triglycerides, menopause, white blood cell count, aging
- MeSH terms
- Body Constitution, Cardiovascular Diseases, Coronary Disease, Factor VII, Female, Fibrinogen, Humans, Life Style, Lipids, Male, Middle Aged, Prospective Studies, Risk Factors, Sex Factors, Smoking, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review